Presentation is loading. Please wait.

Presentation is loading. Please wait.

Abbas Emaminia, MD, Damien J

Published byGarry Morgan Modified over 5 years ago

Similar presentations

Presentation on theme: "Abbas Emaminia, MD, Damien J"— Presentation transcript:

1 Adenosine A2A Agonist Improves Lung Function During Ex Vivo Lung Perfusion 
Abbas Emaminia, MD, Damien J. LaPar, MD, MS, Yunge Zhao, MD, PhD, John F. Steidle, MS, David A. Harris, BS, Victor E. Laubach, PhD, Joel Linden, PhD, Irving L. Kron, MD, Christine L. Lau, MD  The Annals of Thoracic Surgery  Volume 92, Issue 5, Pages (November 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Lungs are placed in the XVIVO evaluation box and are connected to ventilator and perfusion system. Blood flow is from left atrium into a reservoir by gravity. It passes a centrifugal pump, is deoxygenated in an oxygenator, and is pumped back into the lung through the pulmonary artery. Pulmonary artery and left atrial pressures are monitored by specially designed cannulas with built-in pressure lines. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Oxygenation index was significantly improved after 5 hours of ex vivo lung perfusion with Steen Solution and A2A agonist compared with lungs perfused with Steen Solution only; *p < (EVLP = ex vivo lung perfusion; A2AR = A2A receptor.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Lungs after 5 hours of ex vivo lung perfusion (EVLP) with A2A agonist revealed significantly lower mean airway pressure compared with control lungs; *p < (A2AR = A2A receptor.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Comparison of wet-dry (W/D) weight ratio between the treatment and control groups. Low edema formation rates were observed in lungs exposed to the A2A agonist; *p < (EVLP = ex vivo lung perfusion; A2AR = A2A receptor.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Tissue level of interferon gamma (IFN-γ) was significantly lower in treatment lungs after 5 hours of ex vivo lung perfusion (EVLP) and exposure to adenosine A2A agonist; *p < (A2AR = A2A receptor.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Abbas Emaminia, MD, Damien J"

Similar presentations

Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow  Patrick E Parrino, MD, Victor E Laubach, PhD, John R.

Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow  Patrick E Parrino, MD, Victor E Laubach, PhD, John R.
Clinical Transplantation of Initially Rejected Donor Lungs After Reconditioning Ex Vivo  Richard Ingemansson, MD, PhD, Atli Eyjolfsson, MD, Lena Mared,

Clinical Transplantation of Initially Rejected Donor Lungs After Reconditioning Ex Vivo  Richard Ingemansson, MD, PhD, Atli Eyjolfsson, MD, Lena Mared,
Aprotinin improves pulmonary function during reperfusion in an isolated lung model  Menen A Mathias, MD, Curtis G Tribble, MD, Jeffrey F Dietz, BS, Richard.

Aprotinin improves pulmonary function during reperfusion in an isolated lung model  Menen A Mathias, MD, Curtis G Tribble, MD, Jeffrey F Dietz, BS, Richard.
Mauer Biscotti, MD, Matthew Bacchetta, MD 

Mauer Biscotti, MD, Matthew Bacchetta, MD 
Bilateral Internal Mammary Artery Use for Coronary Artery Bypass Grafting Remains Underutilized: A Propensity-Matched Multi-Institution Analysis  Damien.

Bilateral Internal Mammary Artery Use for Coronary Artery Bypass Grafting Remains Underutilized: A Propensity-Matched Multi-Institution Analysis  Damien.
Modified In Vivo Lung Perfusion for Local Chemotherapy: A Preclinical Study With Doxorubicin  Pedro Reck dos Santos, MD, MS, Jin Sakamoto, MD, Manyin.

Modified In Vivo Lung Perfusion for Local Chemotherapy: A Preclinical Study With Doxorubicin  Pedro Reck dos Santos, MD, MS, Jin Sakamoto, MD, Manyin.
Mary E. Huerter, MD, MA, Ashish K

Mary E. Huerter, MD, MA, Ashish K
Jason F. Goldberg, MD, Travis P

Jason F. Goldberg, MD, Travis P
Lily E. Johnston, MD, MPH, Jennifer L. Kirby, MD, PhD, Emily A

Lily E. Johnston, MD, MPH, Jennifer L. Kirby, MD, PhD, Emily A
Keiji Ohata, MD, Toyofumi F

Keiji Ohata, MD, Toyofumi F
Rapamycin Blocks Fibrocyte Migration and Attenuates Bronchiolitis Obliterans in a Murine Model  Jacob R. Gillen, MD, Yunge Zhao, MD, PhD, David A. Harris,

Rapamycin Blocks Fibrocyte Migration and Attenuates Bronchiolitis Obliterans in a Murine Model  Jacob R. Gillen, MD, Yunge Zhao, MD, PhD, David A. Harris,
Pablo G. Sanchez, MD, PhD, Keshava Rajagopal, MD, PhD, Si M

Pablo G. Sanchez, MD, PhD, Keshava Rajagopal, MD, PhD, Si M
Ex Vivo Evaluation of Nonacceptable Donor Lungs

Ex Vivo Evaluation of Nonacceptable Donor Lungs
Short-Course Rapamycin Treatment Preserves Airway Epithelium and Protects Against Bronchiolitis Obliterans  Jacob R. Gillen, MD, Yunge Zhao, MD, PhD,

Short-Course Rapamycin Treatment Preserves Airway Epithelium and Protects Against Bronchiolitis Obliterans  Jacob R. Gillen, MD, Yunge Zhao, MD, PhD,
Severe Pulmonary Valve Regurgitation 40 Years After Blunt Chest Trauma

Severe Pulmonary Valve Regurgitation 40 Years After Blunt Chest Trauma
J. Hunter Mehaffey, MD, Eric J. Charles, MD, Ashish K

J. Hunter Mehaffey, MD, Eric J. Charles, MD, Ashish K
Ex Vivo Bilateral Pulmonary Embolectomy for Donor Lungs Prior to Transplantation  Mohammad Shihata, MD, Nitin Ghorpade, MD, Dale Lien, MD, Dennis Modry,

Ex Vivo Bilateral Pulmonary Embolectomy for Donor Lungs Prior to Transplantation  Mohammad Shihata, MD, Nitin Ghorpade, MD, Dale Lien, MD, Dennis Modry,
Sameer A. Hirji, BS, John C. Haney, MD, Ian Welsby, MD, Frederick W

Sameer A. Hirji, BS, John C. Haney, MD, Ian Welsby, MD, Frederick W
Hospital Variation in Mortality From Cardiac Arrest After Cardiac Surgery: An Opportunity for Improvement?  Damien J. LaPar, MD, MS, Ravi K. Ghanta, MD,

Hospital Variation in Mortality From Cardiac Arrest After Cardiac Surgery: An Opportunity for Improvement?  Damien J. LaPar, MD, MS, Ravi K. Ghanta, MD,
Improved Myocardial Perfusion and Thickening After Off-Pump Revascularization: 5- Year Follow-Up  Chang Young Kim, MD, Ho Young Hwang, MD, Jin Chul Paeng,

Improved Myocardial Perfusion and Thickening After Off-Pump Revascularization: 5- Year Follow-Up  Chang Young Kim, MD, Ho Young Hwang, MD, Jin Chul Paeng,

Similar presentations

Ads by Google